ACCEPTED INTO LOXO-305 CLINICAL TRIAL - CLL Support

CLL Support

23,335 members40,035 posts

ACCEPTED INTO LOXO-305 CLINICAL TRIAL

steve5441 profile image
9 Replies

LOXO-305 TRIAL UPDATE TWO MONTHS IN

Hey everyone, I started this trial on 2/02/2020 at Memorial Sloan Kettering in NJ. After being diagnosed in 2009 with CLL, I have been through 3 prior treatments, FCR, Ibrutinib and Venclaxta. I had a 5 1/2 year remission with FCR, 3 with Ibrutinib,and about 18 months with Venclaxta. After my relapse in December 2019, I was offered a place in the LOXO trial. BMB, CT Scan and numerous blood tests were all completed prior to acceptance, I almost missed the trial because my platelets were too low, 29. I started the dosing with the max amount of 300 mg. There is quite a bit of testing for the first 30 days, then it slows down. I've had zero reactions to the drug, so far so good. My ANC has gone from .9 to 2.9 platelets 29 to 113 and all of the reds have improved greatly. Dr. Mato is very happy, and so am I. My CLL loves my bone marrow and always sets up lodging there, my routine blood testing tells all, I always get very anemic. Never had a swollen gland, node or organ. My 11q and a few other abnormal deletions and mutations has put me into a higher risk category. There will about 150 patients in this phase 1 study worldwide , MSK is going to have about 50 of the slots. From what I am being told, a good number of the participants are getting good responses. We all hope it continues.

Written by
steve5441 profile image
steve5441
To view profiles and participate in discussions please or .
Read more about...
9 Replies
PlanetaryKim profile image
PlanetaryKim

Congrats! Sounds like you re getting good results very quickly!

AussieNeil profile image
AussieNeilPartnerAdministrator

Loxo-305 is one of many second generation BTK inhibitors but not much discussed, so I hope you don't mind me adding you in as an additional trial contact: healthunlocked.com/cllsuppo...

Great to hear of your early promising response.

Neil

steve5441 profile image
steve5441 in reply toAussieNeil

Any thing to possibly help.

cajunjeff profile image
cajunjeff

Steve it sounds as if you are off to great start with your trial. That’s an impressive jump with your platelets. I am sure you were happy to see that. I look forward to reading updates on your trial. It’s nice to know we might get a second chance with a btk drug if we become resistant to the covalent binding versions.

Teddo profile image
Teddo

That is great news for you. Wish you cont'd progress.

ellendram profile image
ellendram

HI Steve- My husband is also on this trial at MSK NJ - glad its going well for you

NaderE profile image
NaderE

Just seeing this post. I started in the Phase 1/2 end of February. I go through MSK in NYC. But since the covid I’ve been getting my tests at Augusta Health. Seems to be working out. Let’s see for how long.

Canuck901 profile image
Canuck901 in reply toNaderE

How tolerable is the drug ? Always. Good to see new and hopefully improved drugs in the pipelines

NaderE profile image
NaderE in reply toCanuck901

So far no apparent side effects. Glad for science and new drugs.

Not what you're looking for?

You may also like...

LOXO-305 UPDATE 7 CYCLES COMPLETE

A while back I posted some results from my LOXO-305 clinical trial. I am now into my 8th 28 day...
steve5441 profile image

LATEST AND GREATEST LOXO-305 UPDATE

About a month or so ago I read a good post about a patients LOXO-305 treatment experiences, which...
steve5441 profile image

Progression Free Survival (PFS) post Discontinuation of Ibrutinib in E1912 Trial

An update re the E1912 trial reported at iwCLL this year - "patients who stopped ibrutinib for...
Jm954 profile image
Administrator

STEP ONE OF MY THIRD CLINICAL TRIAL huCAR-T19 IL-18

With the ink barely dry on my clinical trial consent forms, it was back up to Penn Medicine for my...
steve5441 profile image

BRUIN Study: phase 1/2 study of Pirtobrutinib (formerly Loxo 305) in relapsed or refractory B-cell malignancies

Patients discontinue BTKi's due to resistance and intolerance. We evaluated the safety and efficacy...
Jm954 profile image
Administrator

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
AussieNeil profile image
AussieNeilAdministrator
CLLerinOz profile image
CLLerinOzAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.